| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA627725 | A | AUC in brain | 4 | tissue-based format | Scientific Literature | |||
| 2. | ALA627726 | A | AUC in serum | 6 | cell-free format | Scientific Literature | |||
| 3. | ALA622509 | A | Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound | 3 | assay format | Scientific Literature | |||
| 4. | ALA636544 | A | Relative brain exposure of the compound | 2 | tissue-based format | Scientific Literature | |||
| 5. | ALA638813 | A | Time taken to decrease plasma concentration to half of its initial concentration after iv administration | 2 | organism-based format | Scientific Literature | |||
| 6. | ALA633033 | A | Half life of the compound | 2 | assay format | Scientific Literature | |||
| 7. | ALA654553 | F | Concentration of compound required to inhibit 50% of viral replication of human immunodeficiency virus in CEM-F cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 8. | ALA654554 | F | Concentration of compound required to inhibit 50% of host cell replication of human immunodeficiency virus in CEM-F cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 9. | ALA663655 | B | Inhibitory activity against deoxycytidine kinase from L1210 cells | 19 | cell-based format | Scientific Literature | |||
| 10. | ALA687640 | F | Cytotoxic dose required to reduce the viability of normal uninfected MT-4 cells. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 11. | ALA686039 | F | Inhibition of HIV-1 replication in human peripheral blood mononuclear cells. | Human immunodeficiency virus 1 | 22 | organism-based format | Scientific Literature | ||
| 12. | ALA686420 | F | Dose required to inhibit cytopathic effect of human immunodeficiency virus replication in MT-4 cells. | Human immunodeficiency virus 1 | 29 | organism-based format | Scientific Literature | ||
| 13. | ALA705954 | F | In vitro inhibition against replication of L1210 murine cells; inactive | Mus musculus | 5 | cell-based format | Scientific Literature | ||
| 14. | ALA704726 | F | Ability to effect the replication of L1210 cells in vitro; IN-Inactive | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA706937 | F | Effective dose achieving 50% protection of MT-4 cells against the cytopathic effect of HIV | Human immunodeficiency virus 1 | 20 | organism-based format | Scientific Literature | ||
| 16. | ALA712756 | F | Cytotoxic dose required to reduce the viability of normal uninfected MT-4 cells by 50% | Homo sapiens | 20 | cell-based format | Scientific Literature | ||
| 17. | ALA736576 | F | Antiviral activity against Moloney murine leukemia virus | Moloney murine leukemia virus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA736577 | F | In vitro inhibitory activity against Moloney murine leukemia virus (M-MULV) replication, a mammalian T-lymphotropic retrovirus | Moloney murine leukemia virus | 24 | organism-based format | Scientific Literature | ||
| 19. | ALA757210 | F | In vitro anti-HIV activity was determined in peripheral blood mononuclear cells. | Homo sapiens | 4 | assay format | Scientific Literature | ||
| 20. | ALA757797 | F | Antiviral activity against HIV-1 in human peripheral blood mononuclear (PBM) cells | Homo sapiens | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!